Fredag 20 November | 16:03:31 Europe / Stockholm
Est. tid*
2027-02-17 08:00 Bokslutskommuniké 2026
2026-12-15 N/A Extra Bolagsstämma 2026
2026-11-04 - Kvartalsrapport 2026-Q3
2026-08-26 - Kvartalsrapport 2026-Q2
2026-06-18 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2026-06-17 - Årsstämma
2026-05-27 - Kvartalsrapport 2026-Q1
2026-02-27 - Bokslutskommuniké 2025
2025-11-27 - Kvartalsrapport 2025-Q3
2025-08-27 - Kvartalsrapport 2025-Q2
2025-06-11 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2025-06-10 - Årsstämma
2025-05-22 - Kvartalsrapport 2025-Q1
2025-02-25 - Bokslutskommuniké 2024
2024-11-21 - Kvartalsrapport 2024-Q3
2024-08-29 - Kvartalsrapport 2024-Q2
2024-05-29 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2024-05-28 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-02-22 - Bokslutskommuniké 2023
2023-12-12 - Extra Bolagsstämma 2023
2023-11-17 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-06-02 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2023-06-01 - Årsstämma
2023-05-22 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-11-16 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-02 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2022-06-01 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-28 - Extra Bolagsstämma 2022
2022-02-09 - Bokslutskommuniké 2021
2021-11-16 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-06-10 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2021-06-09 - Årsstämma
2021-05-19 - Kvartalsrapport 2021-Q1
2021-02-25 - Bokslutskommuniké 2020
2020-11-19 - Kvartalsrapport 2020-Q3
2020-09-29 - Extra Bolagsstämma 2020
2020-08-28 - Kvartalsrapport 2020-Q2
2020-06-11 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2020-06-10 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-30 - Kvartalsrapport 2019-Q2
2019-08-28 - Extra Bolagsstämma 2019
2019-06-19 - Årsstämma
2019-06-12 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2019-05-23 - Kvartalsrapport 2019-Q1
2019-02-22 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-30 - Kvartalsrapport 2018-Q2
2018-06-14 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2018-06-13 - Årsstämma
2018-05-24 - Kvartalsrapport 2018-Q1
2018-04-19 - Extra Bolagsstämma 2018
2018-02-22 - Bokslutskommuniké 2017
2017-11-14 - Kvartalsrapport 2017-Q3
2017-08-23 - Kvartalsrapport 2017-Q2
2017-06-22 - X-dag ordinarie utdelning CRNO B 0.00 SEK
2017-06-21 - Årsstämma
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-22 - Bokslutskommuniké 2016
2016-11-11 - Kvartalsrapport 2016-Q3
2016-09-09 - Extra Bolagsstämma 2016
2016-08-24 - Kvartalsrapport 2016-Q2
LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
Cereno Scientific är verksamt inom bioteknik. Bolaget är specialiserat inom läkemedelsutveckling av vanliga och sällsynta kardiovaskulära sjukdomar. Den främsta läkemedelskandidaten utvecklas för behandling av den sällsynta sjukdomen pulmonell arteriell hypertension, samt för trombosindikationer. Särskilt används epigenetisk modulering för att utveckla behandlingar för behövande patienter med kardiovaskulära sjukdomar. Cereno Scientifics huvudkontor ligger i Mölndal.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Cereno Scientific invites shareholders and investors to a digital investor meeting and Q&A

2026-11-20 13:00:00

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech company pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, invites shareholders, investors and other interested parties to a digital investor meeting on Friday, November 27, 2026. The meeting follows the announcement of the intended rights issue and will focus on the Company's financing and priorities going forward.

On November 12, 2026, Cereno Scientific announced its intention to carry out a rights issue of units totaling approximately SEK 400 million. The announcement has raised questions and concerns among shareholders, which the Company wishes to address and clarify.

In response to requests for further information and dialogue, Cereno Scientific is hosting a digital investor meeting dedicated primarily to answering questions from shareholders and investors. Following a brief introduction by the Company, an external moderator will lead the Q&A session.

Shareholders and other interested parties are encouraged to submit questions in advance. Questions will be grouped by topic and addressed during the meeting, with a focus on the planned rights issue, the Company's financial position and its plans going forward.

Sten R. Sörensen, CEO of Cereno Scientific, comments:"We want to give our shareholders a clearer understanding of the planned financing, how the proceeds will be used and our priorities going forward. The meeting provides an opportunity to explain the rationale behind the proposal in greater detail and answer shareholders' questions. We value our shareholders' engagement and welcome questions both ahead of and during the meeting."

Meeting details

Date: Friday, November 27, 2026
Time: 12:00 CET
Meeting link: https://www.youtube.com/live/TrJ6mJAm1Qw
Submit questions to: fraga@investorstudios.se
Deadline for submitting questions: November 25, 2026

The meeting is open to shareholders, investors and other interested parties. A recording of the meeting, together with a summary of the questions and answers, will be made available on the Company's website, www.cerenoscientific.com, following the meeting.